Infographic | July 12, 2022

Use Of Consultants For CDMO Selection

Source: ISR Reports

In Q22022, ISR asked 99 outsourcers whether the company they work for uses consultants to help guide their CDMO selection process. Two-fifths (42%) of respondents confirmed the practice. The use of consultants during CDMO selection is popular at both large biopharma companies with an annual R&D of $1B+ and non-large companies with an annual R&D <$1B, (38% and 46%, respectively). Be on the lookout for ISR’s CDMO Outsourcing Models (3rd Edition) for more insights.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online